Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 7208429, 7 pages
http://dx.doi.org/10.1155/2016/7208429
Research Article

The Effect of Diabetes Medication on Cognitive Function: Evidence from the PATH Through Life Study

Centre for Research in Ageing Health and Wellbeing, Australian National University, Canberra, ACT 0200, Australia

Received 9 February 2016; Accepted 14 March 2016

Academic Editor: Elísio Costa

Copyright © 2016 Pushpani M. Herath et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Craft and G. S. Watson, “Insulin and neurodegenerative disease: shared and specific mechanisms,” The Lancet Neurology, vol. 3, no. 3, pp. 169–178, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. M. W. J. Strachan, R. M. Reynolds, R. E. Marioni, and J. F. Price, “Cognitive function, dementia and type 2 diabetes mellitus in the elderly,” Nature Reviews Endocrinology, vol. 7, no. 2, pp. 108–114, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. W. A. Banks, J. B. Owen, and M. A. Erickson, “Insulin in the brain: there and back again,” Pharmacology and Therapeutics, vol. 136, no. 1, pp. 82–93, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. C. T. Kodl and E. R. Seaquist, “Cognitive dysfunction and diabetes mellitus,” Endocrine Reviews, vol. 29, no. 4, pp. 494–511, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Testa and D. C. Simonson, “Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial,” The Journal of the American Medical Association, vol. 280, no. 17, pp. 1490–1496, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. T. J. Gradman, A. Laws, L. W. Thompson, and G. M. Reaven, “Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus,” Journal of the American Geriatrics Society, vol. 41, no. 12, pp. 1305–1312, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. G. S. Meneilly, E. Cheung, D. Tessier, C. Yakura, and H. Tuokko, “The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes,” Journals of Gerontology, vol. 48, no. 4, pp. M117–M121, 1993. View at Google Scholar · View at Scopus
  8. L. He, A. Sabet, S. Djedjos et al., “Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein,” Cell, vol. 137, no. 4, pp. 635–646, 2009. View at Publisher · View at Google Scholar
  9. K. Łabuzek, D. Suchy, B. Gabryel, A. Bielecka, S. Liber, and B. Okopień, “Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide,” Pharmacological Reports, vol. 62, no. 5, pp. 956–965, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Kirpichnikov, S. I. McFarlane, and J. R. Sowers, “Metformin: an update,” Annals of Internal Medicine, vol. 137, no. 1, pp. 25–33, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Craft, L. D. Baker, T. J. Montine et al., “Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial,” Archives of Neurology, vol. 69, no. 1, pp. 29–38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Ott, C. Benedict, B. Schultes, J. Born, and M. Hallschmid, “Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism,” Diabetes, Obesity and Metabolism, vol. 14, no. 3, pp. 214–221, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. K. J. Anstey, H. Christensen, P. Butterworth et al., “Cohort profile: the PATH through life project,” International Journal of Epidemiology, vol. 41, no. 4, Article ID dyr025, pp. 951–960, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Stafford, H. Hemingway, S. A. Stansfeld, E. Brunner, and M. Marmot, “Behavioural and biological correlates of physical functioning in middle aged office workers: the UK Whitehall II study,” Journal of Epidemiology and Community Health, vol. 52, no. 6, pp. 353–358, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. D. C. Delis, J. H. Kramer, E. Kaplan, and B. A. Ober, California Verbal Learning Test, Psychological Corporation/Harcourt Brace Jovanovich, San Antonio, Tex, USA, 1987.
  16. D. Wechsler, “A standardized memory scale for clinical use,” The Journal of Psychology, vol. 19, no. 1, pp. 87–95, 1945. View at Publisher · View at Google Scholar
  17. A. Baddeley, H. Emslie, and I. Nimmo-Smith, The Spot-the-Word Test, Thames Valley Test Company, Bury St Edmunds, UK, 1992.
  18. A. Smith, Symbol Digit Modalities Test (SDMT) Manual, Western Psychological Services, Los Angeles, Calif, USA, 1982.
  19. K. J. Anstey, K. Dear, H. Christensen, and A. F. Jorm, “Biomarkers, health, lifestyle, and demographic variables as correlates of reaction time performance in early, middle, and late adulthood,” Quarterly Journal of Experimental Psychology Section A: Human Experimental Psychology, vol. 58, no. 1, pp. 5–21, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. R. M. Reitan, “Validity of the Trail Making Test as an indicator of organic brain damage,” Perceptual and Motor Skills, vol. 8, no. 3, pp. 271–276, 1958. View at Google Scholar
  21. J. Tiffin and E. J. Asher, Perdue Pegboard Test; Examiner Manual, Science Research Associates, Chicago, Ill, USA, 1968.
  22. F. Grodstein, J. Chen, R. S. Wilson, and J. E. Manson, “Type 2 diabetes and cognitive function in community-dwelling elderly women,” Diabetes Care, vol. 24, no. 6, pp. 1060–1065, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Logroscino, J. H. Kang, and F. Grodstein, “Prospective study of type 2 diabetes and cognitive decline in women aged 70–81 years,” British Medical Journal, vol. 328, no. 7439, article 548, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Samaras, H. L. Lutgers, N. A. Kochan et al., “The impact of glucose disorders on cognition and brain volumes in the elderly: the Sydney Memory and Ageing Study,” Age, vol. 36, no. 2, pp. 977–993, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. P. K. Elias, M. F. Elias, R. B. D'Agostino et al., “NIDDM and blood pressure as risk factors for poor cognitive performance: the Framingham Study,” Diabetes Care, vol. 20, no. 9, pp. 1388–1395, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. M. A. Espeland, M. E. Miller, J. S. Goveas et al., “Cognitive function and fine motor speed in older women with diabetes mellitus: results from the women's health initiative study of cognitive aging,” Journal of Women's Health, vol. 20, no. 10, pp. 1435–1443, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. E. M. Moore, A. G. Mander, D. Ames et al., “Increased risk of cognitive impairment in patients with diabetes is associated with metformin,” Diabetes Care, vol. 36, no. 10, pp. 2981–2987, 2013. View at Publisher · View at Google Scholar
  28. T. P. Ng, L. Feng, K. B. Yap, T. S. Lee, C. H. Tan, and B. Winblad, “Long-term metformin usage and cognitive function among older adults with diabetes,” Journal of Alzheimer's Disease, vol. 41, no. 1, pp. 61–68, 2014. View at Publisher · View at Google Scholar · View at Scopus